Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volinanserin in Sleep Maintenance Insomnia (SAMS)
NCT00464061Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of volinanserin in Sleep initiation and maintenance disorder, sponsored by Sanofi. Started Apr 2007; status: terminated.
02
Drugs
volinanserin
03
Conditions
Sleep initiation and maintenance disorder
Beyond the preview
Go deeper on NCT00464061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464061.